Sponsor Pipeline

Jubilant Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-07 NCT07751744 Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in… Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07612280 Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in… Essential Thrombocythemia (ET) Recruiting
NCT07751744 Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in… Brain Metastases From Solid Tumors Not Yet Recruiting
Disease Areas
Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1) Glioblastoma (1) Glioma (1)
Get alerts when Jubilant Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free